Close Menu

gene editing

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Horizon Discover today said it is collaborating with the Rosalind Franklin University of Medical Sciences to develop a human cellular disease model of cystic fibrosis.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Precision BioSciences has filed a fifth lawsuit against French company Cellectis alleging patent infringement.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Cellectis bioresearch and Indian contract research organization Syngene International said today they will co-develop novel genetically customized cell lines.

By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – French firm Cellectis and North Carolina-based Precision Biosciences have filed two new suits against each other alleging infringement of US patents covering modified meganucleases.

Using a combination of multiplex automated genome engineering (MAGE) and conjugative assembly genome engineering (CAGE), a research team has generated bacterial strains in which one stop codon has been replaced with another.

The research partners will use induced pluripotent stem cells and zinc-finger nuclease editing tools to study a genetic desert region linked to coronary artery disease.

The TAL Effector technology allows for the design of proteins that bind to any specified sequence of DNA — an approach that promises precise functional control over genetic circuitry.

Cellectis is targeting global distribution of its Talen Access service and Wako will allow the firm to enter the Japanese market "effectively."

The two parties will collaborate on creating a gene editing process in inducible human pluripotent stem cells.

Pages

Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.

US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.

The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.

In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.